301128SZSE

2025 Annual Report of Independent Director (Xu Shui)

✨ AI Summary

This report outlines the performance of Xu Shui as an independent director of Shenzhen Qiangrui Precision Technology Co., Ltd. since June 23, 2025. Key activities included attending 7 board meetings and 3 shareholder meetings, where all proposals were approved without dissent. The report emphasizes the commitment to uphold shareholder interests and compliance with relevant regulations.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

2025 Annual Report of Independent Director

Dear Shareholders,

I have been appointed as an independent director of Shenzhen Qiangrui Precision Technology Co., Ltd. (hereinafter referred to as "the Company") since June 23, 2025. As an independent director, I strictly adhere to the relevant laws and regulations, including the Company Law, Securities Law, and the Shenzhen Stock Exchange's self-regulatory guidelines for listed companies, as well as the Company's Articles of Association and the Independent Director System. During my tenure, I have faithfully, diligently, and responsibly fulfilled my duties as an independent director, personally attending board meetings and shareholder meetings, carefully reviewing various proposals, and providing independent opinions on all matters without being influenced by major shareholders or related parties, thereby maintaining the independence and professionalism of the independent director role and effectively safeguarding the interests of the Company and its shareholders.

I. Basic Information of the Independent Director

(1) Work Experience, Professional Background, and Concurrent Positions

I, Xu Shui, born in 1976, hold Chinese nationality and do not have permanent residency abroad. I have a master's degree and am a senior accountant. My work experience includes:

  • Financial head at Shenzhen Guodan Health Medical Co., Ltd. from July 2014 to September 2015.
  • Financial head and board secretary at Shenzhen Xisi Medical Beauty Hospital Co., Ltd. from October 2015 to April 2017.
  • Financial head at Shenzhen Nairui Technology Co., Ltd. from May 2017 to July 2017.
  • Financial head at Shenzhen Lewei Innovation Technology Co., Ltd. from December 2017 to March 2019.
  • Securities broker and client manager at Guohai Securities from April 2019 to November 2020 and from January 2021 to February 2022.
  • Tax consultant at Shenzhen Jinqian Enterprise Consulting Co., Ltd. from March 2022 to October 2022.
  • Partner at Lixin Accounting Firm (Special General Partnership) from November 2022 to September 2025.
  • Legal representative and director at Shenzhen Zhiyuan Management Consulting Co., Ltd. since October 2025.
  • Legal representative and director at Zhengdan Zhiyuan (Shenzhen) Management Consulting Co., Ltd. since December 2025.
  • Independent director of the Company since June 2025.

(2) Independence Statement

During my tenure as an independent director, I have not held any position other than that of independent director in the Company or its major shareholders. There are no relationships that hinder my ability to make independent and objective judgments, and I meet the independence requirements set forth in the relevant laws and regulations.

II. Annual Performance Overview of the Independent Director

During my tenure in 2025, I attended shareholder meetings, board meetings, and special committee meetings, diligently fulfilling my duties as an independent director.

(1) Attendance at Board and Shareholder Meetings

During my tenure in 2025, I attended 7 board meetings and 3 shareholder meetings. I actively participated in all meetings, fulfilling my obligations as an independent director without any absences or delegations. My attendance record is as follows:

Independent Director NameStatusRequired Board MeetingsActual Attendance (In-person/Remote)Delegated AttendanceAbsencesConsecutive AbsencesShareholder Meetings Attended
Xu ShuiIn office77 (7/0)00No3

To further enhance my performance, I carefully reviewed all proposals, gained a thorough understanding of the Company's overall production and operational conditions, actively participated in discussions, and provided reasonable suggestions, contributing positively to the board's decision-making.

In 2025, the procedures for convening and holding board and shareholder meetings complied with legal requirements, and all major operational decisions were executed legally and effectively. I voted in favor of all proposals reviewed by the board and shareholder meetings, with no dissenting or abstaining votes.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.